Literature DB >> 35219091

Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350].

Alex Friedlaender1, Jarushka Naidoo2, Giuseppe Luigi Banna3, Giulio Metro4, Patrick Forde5, Alfredo Addeo6.   

Abstract

Entities:  

Year:  2022        PMID: 35219091     DOI: 10.1016/j.ctrv.2022.102358

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  1 in total

1.  Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later?

Authors:  Timothée Olivier; Vinay Prasad
Journal:  Transl Oncol       Date:  2022-08-04       Impact factor: 4.803

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.